Page 235 - Academic Press Encyclopedia of Physical Science and Technology 3rd BioTechnology
P. 235

P1: GTV/GWT  P2: GRB/GJP  QC: FYDFinal Pages
 Encyclopedia of Physical Science and Technology  EN011J-559  July 25, 2001  18:57







              Pharmacokinetics                                                                            813

              for large amounts of fat in a body when calculating  Age, sex, and disease states such as hepatic cirrhosis,
              the LBM:                                          renal failure, and congestive heart failure affect drug bind-
                                                                ing and distribution. These will be discussed below.
                  LBM obesity = IBW + 0.3(TBM − IBW).   (14)
              In some cases, the postsurgical or septic patient will be-  IV. DRUG METABOLISM
              come severely edematous and take on 10–20Lof fluid.   AND ELIMINATION
              Since this expansion occurs chiefly in the extracellular
              space, drugs will distribute to the edematous space. This
                                                                As illustrated in Fig. 2, once a drug is absorbed and dis-
              additional weight must be added to the IBW, which can be
                                                                tributed, it will enter the elimination phase. It may be re-
              estimated from the patient’s height, or alternatively, can be
                                                                moved directly by the kidney and appear unchanged in
              added to the LBM calculated from the admission height
                                                                the urine. Or it can be taken up by the liver or another
              and weight.
                                                                organ and metabolized to secondary products, which are
                                                                secreted into the biliary system or are cleared by the kid-
                                                                ney. If the patient is in renal failure, some form of renal
              B. Binding
                                                                replacement therapy will be initiated, and drug circulating
              There is typically a large difference between the apparent  in the plasma will be cleared to the dialysate according to
              volumeofdistribution, V d ,andtheactualanatomicvolume  the degree of plasma binding and the molecular size of the
              which contains the drug, V anat . The volume V anat cannot  free drug.
              exceed the total body water, which is equal to approxi-
              mately 60% of the lean body mass. The total body water  A. Renal Excretion
              is approximately two-thirds intracellular and one-third ex-
              tracellular. The extracellular space is further divided into  Approximately 20% of the cardiac output circulates
              intravascular (7–8% of LBM, with the plasma taking up  through the kidneys. As the blood passes through each
              4–5% and the red cells taking up the rest) and extravascu-  glomerulus, a portion is filtered at the glomerular filtration
              lar space (11–12% of the LBM). A drug with no binding  rate (GFR). GFR decreases with age, and can be estimated
              will have V d which matches one of these volumes. A drug  from the Cockcroft–Gault relationship:
              which is highly bound to plasma proteins (>99%) may
                                                                                (140 − age) × IBW(kg)
              have an apparent volume of distribution many times its  GFR men =                      .    (15)
                                                                             72 × serum creatinine (mg/dl)
              actual volume of distribution, which would approximate
              the intravascular space.                          The GFR women is found by multiplying Eq. (15) by 0.85.
                Binding to plasma proteins usually restricts movement  IBW is defined by Eqs. (13a) and (13b); age is in years;
              of the drug out of the vasculature. Since albumin is the  serum creatinine is measured. Solutes of low molecular
              most important protein with respect to binding, states of  weight (<6000 Da) which are not bound to protein are fil-
              altered serum albumin concentrations, such as pregnancy,  tered at the same rate as plasma water. Larger molecules or
              liver dysfunction, or the nephrotic syndrome, can change  those bound to proteins will pass through the glomerulus at
              the free plasma concentration of a highly bound drug and  a slower rate than the GFR. Macromolecules with anionic
              significantly influence the distribution and elimination of  charges are further restricted in their passage through the
              a drug. α 1 -Acid glycoprotein is another important binding  normal glomerulus when compared with molecules with
              protein for basic drugs. Its molecular weight is 40,000 Da  neutral or positive charges. The glomerular filtrate in the
              and it will therefore pass through the capillary endothe-  tubule is further modified in the proximal tubule by reab-
              lium. Since it is an acute-phase reactant, its concentration  sorption or secretion of substances. Diuretic medications
              in plasma increases with states of inflammation or cancer  such as hydrochlorothiazide, furosemide, and amiloride
              but falls with pregnancy or nephrosis. Other proteins play  are secreted in the proximal tubule and act on transporters
              a minor role in drug binding.                     located on the apical side of the tubule further along in the
                In addition to plasma proteins, cellular elements and  nephron.
              tissues bind drugs. For example, it has been demon-  For a drug whose transport is not limited by renal blood
              strated that significant amounts of acetazolamide, pheny-  flow, the following expression can be used to calculate
              toin, propanolol, and quinidine are taken up in red blood  renal clearance (Clr kidney ):
              cells. Drug binding to tissues is important but poorly un-
                                                                       Clr kidney = f d (GFR + Clr KS )(1 − f R ),  (16)
              derstood, with the chief effect being on the time course of
              the drug. A decrease in tissue binding results in a decrease  where f d is the free drug fraction in blood, Clr KS is the rate
              in the half-life of the drug.                     of renal tubular secretion of drug, and f R is the fraction
   230   231   232   233   234   235   236   237   238   239   240